TheraRadar
← Back
Data updated: Mar 29, 2026

BEIJING JIALIN

Pharmaceuticals
Generics

BEIJING JIALIN is a generic drug manufacturer with 1 FDA-approved products.

2024
Since
1
Drugs
-
Trials
15
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

OSELTAMIVIR PHOSPHATE 2026-01-22
OSELTAMIVIR PHOSPHATE 2026-01-15
Labeling
OSELTAMIVIR PHOSPHATE 2025-10-02
Manufacturing (CMC)
OSELTAMIVIR PHOSPHATE 2025-07-09
OSELTAMIVIR PHOSPHATE 2025-03-03
Labeling
OSELTAMIVIR PHOSPHATE 2025-03-03
Labeling
OSELTAMIVIR PHOSPHATE 2025-03-03
Labeling
OSELTAMIVIR PHOSPHATE 2025-03-03
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

No indication data

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...